NASDAQ$ESTA
Establishment Labs Holdings Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Reported a slight increase in revenue and updated 2023 revenue guidance, while experiencing a wider loss from operations compared to the previous year.
Establishment Labs reported a slight increase in third-quarter revenue, up 0.8% year-over-year to $38.5 million. The company updated its 2023 revenue guidance to approximately $165 million, representing a 2% increase over 2022. However, the loss from operations widened to $21.0 million, and the net loss increased to $29.3 million.
- Third quarter worldwide revenue increased 0.8% year-over-year to $38.5 million.
- 2023 revenue guidance updated to approximately $165 million, an increase of 2% over 2022.
- Third quarter loss from operations was $21.0 million.
- Cash balance of $52.2 million as of September 30, 2023.
Headline financials
Revenue & EPS history
Establishment Labs · Revenue · Quarterly
$38.5M
Forward guidance
Establishment Labs updated its 2023 revenue guidance to approximately $165 million, an increase of 2% over 2022.
Tailwinds
- Expected China approval in 2023.
- Taking market share globally.
- Launch of Motiva into the US and China.
- Global rollout of Mia Femtech.
- Expect strong growth for many years to come.
Headwinds
- Lower demand for breast procedures globally.
- Cycles of reduced demand in our industry are transitory.
- Removed China approval from forecasts.
- Loss from operations was $21.0 million compared to a loss of $10.5 million in the year-ago period.
- Cash decreased $14.2 million from December 31, 2022.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+1.5%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+2.4%
Avg return
30 days after
56%
18 / 32 earnings
Positive
+22.5%
Q3 2025
Best reaction
-26.0%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -4.3% | +2.9% | |
| Q4 2025 | -1.9% | +5.0% | -20.1% | |
| Q3 2025 | +22.5% | +37.0% | +43.2% | |
| Q1 2025 | +4.9% | +5.1% | +14.2% | |
| Q4 2024 | +17.9% | +28.1% | +12.1% | |
| Q3 2024 | -5.2% | -13.2% | -10.0% | |
| Q2 2024 | +3.4% | +20.6% | +23.5% | |
| Q1 2024 | +5.4% | +4.2% | -10.8% | |
| Q4 2023 | +15.1% | +19.6% | +28.2% | |
| Q3 2023 | -26.0% | -36.1% | -31.7% | |
| Q2 2023 | -8.4% | -12.0% | -12.2% | |
| Q1 2023 | +1.8% | -1.6% | -1.9% | |
| Q4 2022 | +7.2% | +10.3% | +0.3% | |
| Q3 2022 | -7.7% | +11.1% | +27.1% | |
| Q2 2022 | -3.0% | +1.3% | -0.4% | |
| Q1 2022 | -10.5% | -10.1% | +2.3% | |
| Q4 2021 | +3.3% | +1.6% | +11.5% | |
| Q3 2021 | -10.6% | -14.3% | -15.2% | |
| Q2 2021 | +6.0% | -3.7% | -3.1% | |
| Q1 2021 | -0.6% | -1.8% | +8.9% | |
| Q4 2020 | +0.4% | -6.8% | +9.5% | |
| Q3 2020 | +8.9% | -0.4% | +22.6% | |
| Q2 2020 | +6.2% | +7.3% | +9.3% | |
| Q1 2020 | +2.9% | +0.5% | +15.3% | |
| Q4 2019 | +4.5% | -16.4% | +0.4% | |
| Q3 2019 | -0.3% | +0.5% | +7.8% | |
| Q2 2019 | -5.2% | -10.6% | -10.2% | |
| Q1 2019 | +1.5% | -0.3% | -15.9% | |
| Q4 2018 | -1.9% | -4.9% | -15.2% | |
| Q3 2017 | +10.3% | +4.5% | -6.2% | |
| Q3 2018 | +10.3% | +4.5% | -6.2% | |
| Q2 2018 | -2.7% | -2.9% | -3.4% | |
| Q4 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro